Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Research crawled date : 2022 - 06 - 06 save search
FUTURUM RESEARCH AND MOOR INSIGHTS & STRATEGY COHOST SIX FIVE SUMMIT WITH EXCITING LINEUP OF LEADING TECH EXPERTS
Published: 2022-06-06 (Crawled : 23:00) - prnewswire.com
ERIC | News | $5.35 1.71% 13M
|
Electronic Technology
|
| O: -0.61%
H: 1.84%
C: 1.71%
research six
Seagen and Genmab Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting
Published: 2022-06-06 (Crawled : 15:20) - biospace.com/
GNMSF | News | $289.67 5.3K
|
Health Technology
|
| O: -0.79%
H: 5.87%
C: 0.32%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 1.77%
H: 0.72%
C: 0.08%
GMAB | News | $28.85 -0.41% 260K
|
Health Technology
|
| O: 0.26%
H: 0.34%
C: -1.81%
tivdak research program asco cancer
Genmab and Seagen Present Data from Tisotumab Vedotin (TIVDAK®) Clinical Development Program and Additional Cervical Cancer Research at ASCO 2022 Annual Meeting
Published: 2022-06-06 (Crawled : 15:20) - globenewswire.com
GNMSF | News | $289.67 5.3K
|
Health Technology
|
| O: -0.79%
H: 5.87%
C: 0.32%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 1.77%
H: 0.72%
C: 0.08%
GMAB | News | $28.85 -0.41% 260K
|
Health Technology
|
| O: 0.26%
H: 0.34%
C: -1.81%
tivdak research program asco cancer
Cumene Market to Reach US$ 42.7 Bn by 2032 - Comprehensive Research Report by Future Market Insights Inc
Published: 2022-06-06 (Crawled : 15:00) - prnewswire.com
RYDAF | $33.69 2K
|
Energy Minerals
|
| O: 0.64%
H: 2.51%
C: 1.34%
research report market
Serotiny Announces a Research Collaboration With Janssen to Optimize Designs for Chimeric Antigen Receptors Signaling Domains
Published: 2022-06-06 (Crawled : 15:00) - biospace.com/
JNJ | News | $150.09 0.65% 4.9M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
research collaboration designation
Global Intravenous Iron Drugs Market Size Estimated to Reach US $4.02 Billion by 2028: Polaris Market Research
Published: 2022-06-06 (Crawled : 14:00) - prnewswire.com
ABBV | News | $169.16 0.76% 2.7M
|
Health Technology
|
| O: -0.12%
H: 0.56%
C: -0.32%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.63%
H: 0.0%
C: 0.0%
RMTI | $1.53 0.99% 28K
|
Health Technology
|
| O: 0.64%
H: 2.93%
C: -5.06%
research market drug
Pulse Oximeters Market to Reach $3.9 Bn, Globally, by 2031 at 6.3% CAGR: Allied Market Research
Published: 2022-06-06 (Crawled : 14:00) - prnewswire.com
MDT | $81.105 0.66% 2.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
PHG | News | $20.95 1.65% 1.7M
|
Health Technology
|
| O: 2.75%
H: 0.0%
C: 0.0%
MASI | $137.02 2.01% 130K
|
Health Technology
|
| O: 1.84%
H: 0.68%
C: -1.39%
research market
Electric hobs Market to Reach $1.0 Billion, Globally, by 2031 at 4.5% CAGR: Allied Market Research
Published: 2022-06-06 (Crawled : 14:00) - prnewswire.com
WHR A | $106.035 0.56% 800K
|
Consumer Durables
|
| O: 0.31%
H: 0.8%
C: -0.45%
POOL | $376.34 2.86% 310K
|
Distribution Services
|
| O: 0.67%
H: 0.81%
C: 0.39%
research market
Amarin Announces Comprehensive Cost Reduction Plan to Address Market Dynamics in U.S. Business
Published: 2022-06-06 (Crawled : 13:20) - biospace.com/
AMRN | News | $0.8888 2.67% 560K
|
Health Technology
|
| O: 12.74%
H: 3.38%
C: -7.34%
market
Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine and Therapy Research and Unlocking Deeper Analytical Insights
Published: 2022-06-06 (Crawled : 13:20) - biospace.com/
TMO | News | $573.855 4.65% 1.7M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
research solutions vaccine therapy
HR Payroll Software Market to Reach $55.69 Bn, Globally, by 2031 at 9.2% CAGR: Allied Market Research
Published: 2022-06-06 (Crawled : 13:20) - prnewswire.com
SAPGF | News | $176.433 1.9K
|
Technology Services
|
| O: 2.56%
H: 0.38%
C: -1.49%
SAP | News | $187.12 5.02% 940K
|
Technology Services
|
| O: 1.61%
H: 0.0%
C: 0.0%
PAYC 4 | $189.6 1.55% 240K
|
Technology Services
|
| O: 1.35%
H: 0.68%
C: -0.18%
ORCL | News | $115.47 0.82% 3M
|
Technology Services
|
| O: -0.07%
H: 3.04%
C: 0.47%
research software market
Agilent Announces New Oligonucleotide Analysis Software for Biopharma Research
Published: 2022-06-06 (Crawled : 13:00) - biospace.com/
A | $139.2 3.95% 1.3M
|
Health Technology
|
| O: 1.18%
H: 0.48%
C: -1.35%
biopharma research software
Connector Market to Garner $114.7 Billion, Globally, By 2030 at 6.6% CAGR: Allied Market Research
Published: 2022-06-06 (Crawled : 13:00) - prnewswire.com
PRYMF | $55.28 270
|
Producer Manufacturing
|
| O: 12.02%
H: 0.0%
C: -11.39%
ABLZF | News | $50.158 1.9K
|
Producer Manufacturing
|
| O: -1.8%
H: 6.09%
C: -0.46%
PRYMY | $26.834 9.2K
|
Manufacturing
|
| O: 2.18%
H: 0.19%
C: -0.5%
TEL | News | $144.5 0.51% 1.6M
|
Electronic Technology
|
| O: 1.22%
H: 1.13%
C: 0.34%
APTV | $70.57 0.67% 770K
|
Producer Manufacturing
|
| O: 0.23%
H: 2.31%
C: 1.26%
APH | $113.9 1.82% 2.4M
|
Electronic Technology
|
| O: 1.03%
H: 1.17%
C: -0.49%
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: 0.76%
H: 0.0%
C: 0.0%
research market
Arcutis Announces Positive Topline Results from STRATUM Pivotal Phase 3 Trial of Roflumilast Foam 0.3% in Seborrheic Dermatitis
Published: 2022-06-06 (Crawled : 12:20) - biospace.com/
ARQT | $8.875 -0.73% 870K
|
Health Technology
|
| O: 4.65%
H: 1.24%
C: -4.42%
topline dermatitis trial positive results phase 3
Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Significantly Improves Progression-Free Survival in Women with Advanced Ovarian Cancer in Primary Efficacy Analyses Regardless of BRCA Mutation and HRD Status
Published: 2022-06-06 (Crawled : 12:20) - biospace.com/
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 15.34%
H: 0.6%
C: -11.11%
rubraca treatment women cancer ovarian cancer
Bruker Launches timsTOF HT with Greater Dynamic Range for Further Enhancing Unbiased, High-Confidence 4D Proteomics™
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
BRKR | $82.95 6.28% 510K
|
Health Technology
|
| O: 0.09%
H: 0.44%
C: -0.77%
Bruker Introduces Novel Point-of-Need Applied Mass Spectrometry Tools for Accelerated Measurements without Chromatography
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
BRKR | $82.95 6.28% 510K
|
Health Technology
|
| O: 0.09%
H: 0.44%
C: -0.77%
tools
Bruker Announces Key Innovations for Highly Multiplexed Spatial Proteomics and Multiomic Tissue Imaging at Large Field-of-View
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
BRKR | $82.95 6.28% 510K
|
Health Technology
|
| O: 0.09%
H: 0.44%
C: -0.77%
imaging
Verastem Oncology Provides Update on RAMP 201 Study Evaluating VS-6766 ± Defactinib in Low-Grade Serous Ovarian Cancer
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
VSTM | $9.72 -0.21% 72K
|
Health Technology
|
| O: 3.05%
H: 0.74%
C: -9.63%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 6.31%
H: 1.07%
C: -2.15%
vs-6766 cancer defactinib ovarian cancer
Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting
Published: 2022-06-06 (Crawled : 12:00) - biospace.com/
ACET | News | $2.09 4.5% 1M
|
Health Technology
|
| O: 2.79%
H: 9.77%
C: 4.16%
adi-001 trial phase 1
Gainers vs Losers
| 86% | 14% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7989 33.15% 3.2M
|
Health Technology
BTCM | $3.51 30.0% 730K
|
Arts, Entertainment, and Recrea...
MLEC | $1.81 29.29% 2.8M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.